A Prospective Study of Risk Factors and Historical Trends in Metronidazole Failure for Clostridium difficile Infection
Open Access
- 31 December 2008
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 6 (12), 1354-1360
- https://doi.org/10.1016/j.cgh.2008.06.024
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Factors Associated With Failure of Metronidazole in Clostridium difficile–associated DiseaseJournal of Clinical Gastroenterology, 2004
- Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoeaJournal of Antimicrobial Chemotherapy, 2004
- Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile DiarrheaInfection Control & Hospital Epidemiology, 2002
- Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficileClinical Infectious Diseases, 2002
- Molecular Fingerprinting of Clostridium difficile Isolates: Pulsed-Field Gel Electrophoresis versus Amplified Fragment Length PolymorphismJournal of Clinical Microbiology, 2002
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaThe Lancet, 2001
- Asymptomatic Carriage ofClostridium difficileand Serum Levels of IgG Antibody against Toxin ANew England Journal of Medicine, 2000
- Intravenous immunoglobulin therapy for severe Clostridium difficile colitisGut, 1997
- Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.1997
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxinThe Journal of Pediatrics, 1991